Zika virus is an arthropod-borne virus primarily transmitted through the bite of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus. The virus belongs to the Flaviviridae family and is related to dengue, West Nile, and yellow fever viruses. First identified in the Zika Forest of Uganda in 1947, the virus gained global attention during the 2015-2016 outbreak in the Americas. While many Zika virus infections are asymptomatic or result in mild flu-like symptoms, the virus has been associated with severe neurological complications, particularly microcephaly in infants born to infected mothers. Zika virus can also be transmitted sexually and through blood transfusions. Efforts to control the spread of Zika include mosquito control measures, public health campaigns, and research into vaccines and antiviral treatments. The global health community continues to monitor and study Zika virus due to its potential to cause outbreaks and its impact on reproductive health. Research efforts aim to enhance our understanding of the virus, improve diagnostics, and develop effective preventive measures.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom